Logo Logo
FAQ
Contact
Switch language to German
App-basiertes Lebensstil-Coaching als Begleittherapie und in der Nachsorge bei Patientinnen mit Mammakarzinom
App-basiertes Lebensstil-Coaching als Begleittherapie und in der Nachsorge bei Patientinnen mit Mammakarzinom
In the last decades, modern oncological medicine has evolved into personalized and risk-adapted individualized medicine. This approach has been primarily pursued for pharmacological, surgical, and radiological therapeutic procedures and has become increasingly important in the field of supportive therapy in recent years. Digital support offerings for breast cancer patients enable filling a gap in care, providing an easily accessible, cost-effective, and location-independent option for individuals to cope with the disease, its treatment, and its side effects. Additionally, they offer relief for hospitals and outpatient oncologists and psychologists and help reduce healthcare costs from an economic perspective. In our research on the effectiveness of the first digital health applications (DiGA) for breast cancer patients, we were able to demonstrate that integrating a digital support offering into the clinical routine of German breast centers is feasible. Furthermore, not only did we observe very high adherence to the intervention, but also positive impacts on the psychological distress and resilience of the affected individuals. These results are independent of age, tumor stage, or the type of therapy, indicating that patients do desire digitization in healthcare, even in conditions that generally affect an older demographic. Due to the heterogeneity of breast cancer and the associated complexity of treatment regimens and resulting side effects, it becomes evident that individualization is taking on an increasingly important role. The S3 and AGO guidelines for breast cancer already recommend app-based support offerings for managing side effects and reducing psychological distress. The PINK! Coach App, based on our research, not only became the first definitive DiGA for breast cancer but was also included in the AGO guidelines. This lays the foundation for widespread digital healthcare provision and further research with the PINK! Coach App.
breast cancer, digital health, apps, chemotherapy, DiGA
Wolff, Josefine
2025
German
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Wolff, Josefine (2025): App-basiertes Lebensstil-Coaching als Begleittherapie und in der Nachsorge bei Patientinnen mit Mammakarzinom. Dissertation, LMU München: Faculty of Medicine
[thumbnail of Wolff_Josephine.pdf]
Preview
PDF
Wolff_Josephine.pdf

1MB

Abstract

In the last decades, modern oncological medicine has evolved into personalized and risk-adapted individualized medicine. This approach has been primarily pursued for pharmacological, surgical, and radiological therapeutic procedures and has become increasingly important in the field of supportive therapy in recent years. Digital support offerings for breast cancer patients enable filling a gap in care, providing an easily accessible, cost-effective, and location-independent option for individuals to cope with the disease, its treatment, and its side effects. Additionally, they offer relief for hospitals and outpatient oncologists and psychologists and help reduce healthcare costs from an economic perspective. In our research on the effectiveness of the first digital health applications (DiGA) for breast cancer patients, we were able to demonstrate that integrating a digital support offering into the clinical routine of German breast centers is feasible. Furthermore, not only did we observe very high adherence to the intervention, but also positive impacts on the psychological distress and resilience of the affected individuals. These results are independent of age, tumor stage, or the type of therapy, indicating that patients do desire digitization in healthcare, even in conditions that generally affect an older demographic. Due to the heterogeneity of breast cancer and the associated complexity of treatment regimens and resulting side effects, it becomes evident that individualization is taking on an increasingly important role. The S3 and AGO guidelines for breast cancer already recommend app-based support offerings for managing side effects and reducing psychological distress. The PINK! Coach App, based on our research, not only became the first definitive DiGA for breast cancer but was also included in the AGO guidelines. This lays the foundation for widespread digital healthcare provision and further research with the PINK! Coach App.